CVIA Journal

It has become a tradition for world renowned cardiology associations to send delegations to GW-ICC congresses.

Professor Jeroen J. Bax, President, European Society of Cardiology (ESC), Professor John Warner, President, American Heart Association (AHA), and Professor Mary N. Walsh, President, American College of Cardiology (ACC), led delegations attending the 28^th GW-ICC, to present latest international guidance, cutting-edge diagnosis and information on treatment with emerging technologies.

Cooperation with these international societies is not limited to their attendance at GW-ICC; GW-ICC also holds reciprocal academic sessions at the annual meetings of these eminent societies, for example GW-ICC @ ACC, GW-ICC @ AHA, and GW @ ESC, to introduce important Chinese academic research.

At the 28^th GW-ICC in 2017, the ESC @ GW-ICC Joint Forum, which was held over four sessions, focused on the highlights of 2017 ESC Congress, to introduce the latest guidance and discuss the latest developments of ESC images, heart disease, heart failure, STEMI and valve disease.

A video of one of these 2017 sessions is now available to view on the GW-ICC YouTube channel:

Interventional Cardiology and Acute Coronary Syndromes

Presenter: Marco Roffi, Geneva University Hospitals, Geneva, Switzerland.

In this presentation Professor Roffi discusses reviews Interventional Cardiology and Acute Coronary Syndromes topics from ESC 2017 with the following take home messages:

• Decision about the optimal revascularization strategy of complex multivessel CAD should take into account age and clinical profile; anatomic complexity and probability for achieving complete functional revascularization, and access to contemporary drug eluting stents.
• With contemporary PCI, de-escalation of long term antithrombotic therapy either chronic DAPT in ACS or dual therapy among selected patients with atrial fibrillation appears to be safe and associated with net clinical benefit.
• The ESC 0/1h algorithm for rapid rule out/in of acute MI is safe and effective and should be extensively implemented.
• Patients with ACS are changing over time: and older age and more comorbidities may account for complications and a worse outcome.
• Younger women with STEMI have a higher mortality as compared with men, even when they receive the appropriate treatment in a timely fashion.

Further information on the 29^th GW-ICC, to be held October 11^th -14^th, 2018, in Beijing, China, is available on the congress website:

http://www.gw-icc2017.org/en/1/index.jsp

Cardiovascular Innovations and Applications (CVIA) is the official journal of the Great Wall International Cardiology Conference (GW-ICC). CVIA supports GW-ICC in its aims of leading the development of cardiovascular medicine in China, by introducing and promoting new concepts and technologies and strengthening and promoting cooperation amongst Chinese and international cardiology experts. CVIA is available on the IngentaConnect platform http://www.ingentaconnect.com/content/cscript/cvia and at https://dhn.zgc.mybluehostin.me/cvia/. Submissions may be made using Scholar One manuscripts at https:/mc04.manuscriptcentral.com/cvia-journal. There are no author submission or article processing fees.

Twitter: @CVIA_Journal

Facebook: https://www.facebook.com/cvia.journal/

Conference website: http://www.gw-icc2017.org/en/1/index.jsp

ESC @ GW-ICC Joint Forum – Great Wall International Congress of Cardiology (GW-ICC) 2017- Preventive Cardiology ESC Congress 2017 Highlights

It has become a tradition for world renowned cardiology associations to send delegations to GW-ICC congresses.

Professor Jeroen J. Bax, President, European Society of Cardiology (ESC), Professor John Warner, President, American Heart Association (AHA), and Professor Mary N. Walsh, President, American College of Cardiology (ACC), led delegations attending the 28^th GW-ICC, to present latest international guidance, cutting-edge diagnosis and information on treatment with emerging technologies.

Cooperation with these international societies is not limited to their attendance at GW-ICC; GW-ICC also holds reciprocal academic sessions at the annual meetings of these eminent societies, for example GW-ICC @ ACC, GW-ICC @ AHA, and GW @ ESC, to introduce important Chinese academic research.

At the 28^th GW-ICC in 2017, the ESC @ GW-ICC Joint Forum, which was held over four sessions, focused on the highlights of 2017 ESC Congress, to introduce the latest guidance and discuss the latest developments of ESC images, heart disease, heart failure, STEMI and valve disease.

A video of one of these 2017 sessions is now available to view on the GW-ICC YouTube channel:

Preventive Cardiology

ESC Congress 2017 Highlights

This presentation covering highlights from preventive cardiology sessions at ESC 2017 discusses how:

• Links between saturated fats, carbohydrates and outcomes are still puzzling and more clarification is needed, including in guideline recommendations;
• Triple vascular screening on the population level seems effective in reducing all-cause mortality. Cost effectiveness indicates it is worthwhile implementing;
• CETP inhibition is a new LDL lowering medication with effect on CVD events;
• PCSK9 inhibition is safe, reduces plaque volume but does not change plaque composition.

Further information on the 29^th GW-ICC, to be held October 11^th -14^th, 2018, in Beijing, China, is available on the congress website:

http://www.gw-icc2017.org/en/1/index.jsp

It has become a tradition for world renowned cardiology associations to send delegations to GW-ICC congresses.

Professor Jeroen J. Bax, President, European Society of Cardiology (ESC), Professor John Warner, President, American Heart Association (AHA), and Professor Mary N. Walsh, President, American College of Cardiology (ACC), led delegations attending the 28^th GW-ICC, to present latest international guidance, cutting-edge diagnosis and information on treatment with emerging technologies.

Cooperation with these international societies is not limited to their attendance at GW-ICC; GW-ICC also holds reciprocal academic sessions at the annual meetings of these eminent societies, for example GW-ICC @ ACC, GW-ICC @ AHA, and GW @ ESC, to introduce important Chinese academic research.

At the 28^th GW-ICC in 2017, the ESC @ GW-ICC Joint Forum, which was held over four sessions, focused on the highlights of 2017 ESC Congress, to introduce the latest guidance and discuss the latest developments of ESC images, heart disease, heart failure, STEMI and valve disease.

A video of one of these 2017 sessions is now available to view on the GW-ICC YouTube channel:

Heart Failure

Presenter: Michel Komajda, Institute of Cardiometabolism and Nutrition (ICAN), Pierre & Marie Curie Paris VI University, Pitié‐Salpétrière Hospital Paris, France.

In this presentation Professor Komajda reviews heart failure topics from ESC 2017:

• Beta blockers, heart rate and atrial fibrillation – afib affects outcomes; BB effects heterogenous
• LVEF and beta blockers – BB post MI prevent HfrEF, reduce mortality in HFmrEF
• Mineralocorticoid receptor antagonists/Potassium – MRAs work in high risk patients, hyperkalemia a problem, potential role of potassium binders
• Adherence to guidelines and outcomes – adherence to guidelines is associated with favorable long-term outcomes in HfrEF
• Diabetes – SGLT2 inhibitors, outcome trials on the way, mechanism unclear
• Exergaming – new approach to improve exercise and beyond
• AF ablation in HF – AF ablation beneficial in HfrEF

Further information on the 29^th GW-ICC, to be held October 11^th -14^th, 2018, in Beijing, China, is available on the congress website:

http://www.gw-icc2017.org/en/1/index.jsp

Cardiovascular Innovations and Applications (CVIA) is the official journal of the Great Wall International Cardiology Conference (GW-ICC). CVIA supports GW-ICC in its aims of leading the development of cardiovascular medicine in China, by introducing and promoting new concepts and technologies and strengthening and promoting cooperation amongst Chinese and international cardiology experts. CVIA is available on the IngentaConnect platform http://www.ingentaconnect.com/content/cscript/cvia and at https://dhn.zgc.mybluehostin.me/cvia/. Submissions may be made using Scholar One manuscripts at https:/mc04.manuscriptcentral.com/cvia-journal. There are no author submission or article processing fees.

Twitter: @CVIA_Journal

Facebook: https://www.facebook.com/cvia.journal/

Conference website: http://www.gw-icc2017.org/en/1/index.jsp

It has become a tradition for world renowned cardiology associations to send delegations to GW-ICC congresses.

Cooperation with these international societies is not limited to their attendance at GW-ICC; GW-ICC also holds reciprocal academic sessions at the annual meetings of these eminent societies, for example GW-ICC @ ACC, GW-ICC @ AHA, and GW @ ESC, to introduce important Chinese academic research.

At the 28^th GW-ICC in 2017, the Turkish Society of Cardiology (TAS) held a Joint Forum. A video of one of these 2017 sessions is now available to view on the GW-ICC YouTube channel:

Main Aspects of Lipid Lowering Therapy in 2017 – Current Guidelines and Future Expectations

Presenter: Dilek Ural, Professor, Department of Cardiology, Koç University, Istanbul, Turkey.

In this presentation Professor Ural reviews the current guidelines for lipid lowering therapy in 2017 and considers what may be implemented in the future.

Further information on the 29^th GW-ICC, to be held October 11^th -14^th, 2018, in Beijing, China, is available on the congress website:

http://www.gw-icc2017.org/en/1/index.jsp

Cardiovascular Innovations and Applications (CVIA) is the official journal of the Great Wall International Cardiology Conference (GW-ICC). CVIA supports GW-ICC in its aims of leading the development of cardiovascular medicine in China, by introducing and promoting new concepts and technologies and strengthening and promoting cooperation amongst Chinese and international cardiology experts. CVIA is available on the IngentaConnect platform http://www.ingentaconnect.com/content/cscript/cvia and at https://dhn.zgc.mybluehostin.me/cvia/. Submissions may be made using Scholar One manuscripts at https:/mc04.manuscriptcentral.com/cvia-journal. There are no author submission or article processing fees.

Twitter: @CVIA_Journal

Facebook: https://www.facebook.com/cvia.journal/

Conference website: http://www.gw-icc2017.org/en/1/index.jsp

It has become a tradition for world renowned cardiology associations to send delegations to GW-ICC congresses.

Cooperation with these international societies is not limited to their attendance at GW-ICC; GW-ICC also holds reciprocal academic sessions at the annual meetings of these eminent societies, for example GW-ICC @ ACC, GW-ICC @ AHA, and GW @ ESC, to introduce important Chinese academic research.

At the 28^th GW-ICC in 2017, the Society for Cardiovascular Angiography and Interventions (SCAI) held a Joint Forum. A video of one of these 2017 sessions is now available to view on the GW-ICC YouTube channel:

EKOS Thrombolysis for Pulmonary Embolism

Presenter: Thach Nguyen, MD, FACC, FSCAI, Methodist Hospital, Merrillville, IN, USA.

Further information on the 29^th GW-ICC, to be held October 11^th -14^th, 2018, in Beijing, China, is available on the congress website:

http://www.gw-icc2017.org/en/1/index.jsp

Cardiovascular Innovations and Applications (CVIA) is the official journal of the Great Wall International Cardiology Conference (GW-ICC). CVIA supports GW-ICC in its aims of leading the development of cardiovascular medicine in China, by introducing and promoting new concepts and technologies and strengthening and promoting cooperation amongst Chinese and international cardiology experts. CVIA is available on the IngentaConnect platform http://www.ingentaconnect.com/content/cscript/cvia and at https://dhn.zgc.mybluehostin.me/cvia/. Submissions may be made using Scholar One manuscripts at https:/mc04.manuscriptcentral.com/cvia-journal. There are no author submission or article processing fees.

Twitter: @CVIA_Journal

Facebook: https://www.facebook.com/cvia.journal/

Conference website: http://www.gw-icc2017.org/en/1/index.jsp

It has become a tradition for world renowned cardiology associations to send delegations to GW-ICC congresses.

Professor Jeroen J. Bax, President, European Society of Cardiology (ESC), Professor John Warner, President, American Heart Association (AHA), and Professor Mary N. Walsh, President, American College of Cardiology (ACC), led delegations attending the 28^th GW-ICC, to present latest international guidance, cutting-edge diagnosis and information on treatment with emerging technologies.

Cooperation with these international societies is not limited to their attendance at GW-ICC; GW-ICC also holds reciprocal academic sessions at the annual meetings of these eminent societies, for example GW-ICC @ ACC, GW-ICC @ AHA, and GW @ ESC, to introduce important Chinese academic research.

At the 28^th GW-ICC in 2017, the AHA @ GW-ICC Joint Forum, which was held over three sessions, focused on population health, guidelines and real-world evidence; cardiovascular disease prevention: hypertension, smoking cessation and blood lipid management and systems of STEMI care.

A video of one of these 2017 sessions is now available to view on the GW-ICC YouTube channel:

Strategies for Beating Cardiovascular Disease in the 21st Century

Presenter: John Warner., MD, President, American Heart Association, Executive Vice President for Health System Affairs, University of Texas Southwestern University Hospitals, Dallas, TX, USA.

Dr Warner discusses how continued investment in secondary prevention and therapeutics, more investments in smoking cessation and broad based efforts to tackle obesity are impacting on cardiovascular disease trends in the 21^st century.

Further information on the 29^th GW-ICC, to be held October 11^th -14^th, 2018, in Beijing, China, is available on the congress website:

http://www.gw-icc2017.org/en/1/index.jsp

Cardiovascular Innovations and Applications (CVIA) is the official journal of the Great Wall International Cardiology Conference (GW-ICC). CVIA supports GW-ICC in its aims of leading the development of cardiovascular medicine in China, by introducing and promoting new concepts and technologies and strengthening and promoting cooperation amongst Chinese and international cardiology experts. CVIA is available on the IngentaConnect platform http://www.ingentaconnect.com/content/cscript/cvia and at https://dhn.zgc.mybluehostin.me/cvia/. Submissions may be made using Scholar One manuscripts at https:/mc04.manuscriptcentral.com/cvia-journal. There are no author submission or article processing fees.

Twitter: @CVIA_Journal

Facebook: https://www.facebook.com/cvia.journal/

Conference website: http://www.gw-icc2017.org/en/1/index.jsp

June 2018: The GW-ICC board is delighted to announce details of upcoming sessions for GW-ICC 2018. The 29^th Great Wall International Cardiology Conference (GW-ICC) takes place from October 11-14, 2018 in Beijing, China.

The conference is jointly hosted by more than twenty Chinese and international cardiovascular organizations covering thirteen academic fields over sixty areas of expertise; and will include more than 400 seminars, training workshops, exhibitions and joint forums that are hosted in conjunction with respected international cardiology associations.

The conference will welcome more than one thousand international delegates from over forty countries; over two thousand Chinese cardiologists and over eighteen thousand other delegates who will share and learn from cutting edge research and innovation in cardiology and related fields.

The GW-ICC 2018 international co-organizing organizations include:

• American College of Cardiology (ACC)
• American Heart Association (AHA)
• Chinese American Academy of Cardiology (CAAC)
• Chinese American Heart Association (CNAHA)
• European Heart Rhythm Association (EHRA)
• European Society of Cardiology (ESC)
• German Society of Cardiology (GSC)
• Heart and Health Foundation of Turkey (HHFT)
• Heart Rhythm Society (HRS)
• International Atherosclerosis Society (IAS)
• Japanese Circulation Society (JCS)
• Korean Society of Cardio Metabolic Syndrome (KSCMS)
• The Society for Cardiovascular Angiography and Intervention (SCAI)
• Transcatheter Cardiovascular Therapeutics (TCT)
• Turkish Atherosclerosis Society (TAS)
• World Heart Federation (WHF

GW-ICC 2018 joint sessions will be hosted by the following organizations:

• American College of Cardiology (ACC)
• American Heart Association (AHA)
• European Society of Cardiology (ESC)
• World Heart Federation (WHF)
• American Heart Association (AHA) – CPR Workshop
• American Heart Association (AHA) – Arteriosclerosis, Thrombosis and Vascular Biology (ATVB)
• American Heart Association (AHA) – Council on Cardiovascular Disease in the Young (CVDY)
• American Heart Association (AHA) – Council on Basic Cardiovascular Sciences (BCVS)
• American Heart Association (AHA) – Genomic and Precision Medicine (GPM)
• Chinese American Academy of Cardiology (CAAC)
• China-German Cardiovascular Forum (CGCF)
• The Society for Cardiovascular Angiography and Intervention (SCAI)
• Heart Rhythm Society (HRS)
• Korean Society of Cardio Metabolic Syndrome (KSCMS)
• European Heart Journal (EHJ)
• Chinese American Heart Association (CNAHA)
• Heart and Health Foundation of Turkey (HHFT)
• Turkish Atherosclerosis Society (TAS)
• GAP Guideline And Practice: Clinical Case-Based Conference (CCBC)
• Transcatheter Cardiovascular Therapeutics (TCT)
• Japanese Circulation Society (JCS)
• European Heart Rhythm Association (EHRA)
• International Atherosclerosis Society (IAS) 

Videos of presentations from GW-ICC 2017 Joint Forum Sessions are available on YouTube at:

https://www.youtube.com/channel/UCirojn054v0gmhmisZyti_Q

 Other GW-ICC 2018 co-hosted sessions include:

American Heart Association (AHA)

Session title: Hypertension 2018: Understanding Genetics, Prevention Strategies and Management

Over a billion people around the world have hypertension, which is said to be the most important risk factor for premature cardiovascular disease. The root causes of hypertension remain unknown. In this session Ivor Benjamin, Professor of Medicine and Director of the Cardiovascular Center at Froedtert & the Medical College of Wisconsin, WI, USA, will discuss studies that are helping us understand genetic origins of high blood pressure and Sidney C. Smith, Jr., Professor of Medicine and Director of the Center for Cardiovascular Science and Medicine at the University of North Carolina, Chapel Hill, NC, USA, will discuss treatment strategies for patients with confirmed hypertension according to the new AHA/ACC hypertension guidelines.

Korean Society of Cardiometabolic Syndrome (KSCMS)

Session title: State-of-Art Cardiometabolic Syndrome

Adequate prevention and treatment are important for prevention of cardiovascular events, development of type 2 diabetes, and dementia. Recent national studies from Korea and USA reported that the prevalence of cardiometabolic syndromes is stable, but not decreasing. State-of-Art pathogenesis, prevention, and treatment will be discussed during this session.

Japanese Circulation Society (JCS)

Session title: Heart Failure Topics – from molecular mechanisms to cutting-edge treatment

Numbers of heart failure patients is rapidly increasing globally. This session will present topics related to heart failure including molecular mechanisms and cutting-edge treatments.

Turkish Atherosclerosis Society (TAS)

Session title: Clinical Links of Pathogenetic Mechanisms in Atherosclerosis

Atherosclerosis is usually silent until the development of a cardiovascular event. Cardiovascular events generally occur before atherosclerosis is detected. The detection of atherosclerotic processes and its related clinical importance is therefore of great significance for prevention. The aim of this session is to evaluate some underlying causes of this condition and their impact on the development of atherosclerosis.

European Heart Journal (EHJ)

Session title: The Year in Cardiology – the EHJ Perspective

Transcatheter Cardiovascular Therapeutics (TCT)

Session title: 30^th TCT Anniversary Perspectives of Interventional Cardiology

Further information on the 29^th GW-ICC, to be held October 11^th -14^th, 2018, in Beijing, China, is available on the congress website:

http://www.gw-icc2017.org/en/1/index.jsp

Cardiovascular Innovations and Applications (CVIA) is the official journal of the Great Wall International Cardiology Conference (GW-ICC). CVIA supports GW-ICC in its aims of leading the development of cardiovascular medicine in China, by introducing and promoting new concepts and technologies and strengthening and promoting cooperation amongst Chinese and international cardiology experts. CVIA is available on the IngentaConnect platform http://www.ingentaconnect.com/content/cscript/cvia and at https://dhn.zgc.mybluehostin.me/cvia/. Submissions may be made using Scholar One manuscripts at https:/mc04.manuscriptcentral.com/cvia-journal. There are no author submission or article processing fees.

Twitter: @CVIA_Journal

Facebook: https://www.facebook.com/cvia.journal/

Conference website: http://www.gw-icc2017.org/en/1/index.jsp

KSCMS @ GW-ICC Joint Forum – Great Wall International Congress of Cardiology (GW-ICC) 2017 – Primary prevention of Diabetes Mellitus in Cardiac Health: Opportunities and Limitations

It has become a tradition for world renowned cardiology associations to send delegations to GW-ICC congresses. Cooperation with these international societies is not limited to their attendance at GW-ICC; GW-ICC also holds reciprocal academic sessions at the annual meetings of these eminent societies to introduce important Chinese academic research.

At the 28^th GW-ICC in 2017, the Korean Society of Cardio metabolic Syndrome (KSCMS) held a Joint Forum. A video of one of these 2017 sessions is now available to view on the GW-ICC YouTube channel:

Primary prevention of Diabetes Mellitus in Cardiac Health: Opportunities and Limitations

Presenter: Mehman Niyazi-ogly Mamedov, National Research Centre for Preventive Research, Moscow, Russia.

Dr Niyazi-ogly Mamedov discusses how economic problems, socio-cultural problems and lack of data/knowledge/skills are barriers to prevention of diabetes mellitus in cardiac care.

Further information on the 29^th GW-ICC, to be held October 11^th -14^th, 2018, in Beijing, China, is available on the congress website:

http://www.gw-icc2017.org/en/1/index.jsp

Cardiovascular Innovations and Applications (CVIA) is the official journal of the Great Wall International Cardiology Conference (GW-ICC). CVIA supports GW-ICC in its aims of leading the development of cardiovascular medicine in China, by introducing and promoting new concepts and technologies and strengthening and promoting cooperation amongst Chinese and international cardiology experts. CVIA is available on the IngentaConnect platform http://www.ingentaconnect.com/content/cscript/cvia and at https://dhn.zgc.mybluehostin.me/cvia/. Submissions may be made using Scholar One manuscripts at https:/mc04.manuscriptcentral.com/cvia-journal. There are no author submission or article processing fees.

Twitter: @CVIA_Journal

Facebook: https://www.facebook.com/cvia.journal/

Conference website: http://www.gw-icc2017.org/en/1/index.jsp